Vitamin D (VD) influences genetic expression through its receptor (VDR). VD pathway gene polymorphisms seem to influence antiviral drug pharmacokinetics and therapeutic outcome/toxicity. We investigated the association between daclatasvir (DCV) plasma concentrations and genetic variants (SNPs) associated with the VD pathway.
Vitamin D pathway gene polymorphisms affecting daclatasvir plasma concentration at 2 weeks and 1 month of therapy
Cusato, Jessica
Co-first
;Nicolò, Amedeo DeCo-first
;Boglione, Lucio;Favata, Fabio;Ariaudo, Alessandra;Pinna, Simone Mornese;Carcieri, Chiara;GUIDO, FEDERICA;Perri, Giovanni Di;D'Avolio, AntonioLast
2018-01-01
Abstract
Vitamin D (VD) influences genetic expression through its receptor (VDR). VD pathway gene polymorphisms seem to influence antiviral drug pharmacokinetics and therapeutic outcome/toxicity. We investigated the association between daclatasvir (DCV) plasma concentrations and genetic variants (SNPs) associated with the VD pathway.
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
cusato2018.pdf
Accesso riservato
Tipo di file:
PDF EDITORIALE
Dimensione
447.01 kB
Formato
Adobe PDF
|
447.01 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
